title: Current and future treatment of Lyme disease.
abstract: Lyme borreliosis, a tick-transmitted spirochetal disease, may begin with a characteristic expanding skin lesion at the site of the tick bite. Within several days to weeks, the infection can spread haematogenously to involve the heart, nervous system or the joints. After months to years, the spirochete may persist in these organs causing a chronic form of illness. All stages of this disease can be treatable with antimicrobial agents.
authors.affiliation: Division of Infectious Diseases, Department of Medicine, State University of New York - Downstate Medical School, Brooklyn, New York, USA.
authors.forename: J
authors.initials: J
authors.lastname: Ravishankar
authors.forename: L I
authors.initials: LI
authors.lastname: Lutwick
mesh_terms: D000328:Adult; D000818:Animals; D000900:Anti-Bacterial Agents / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D019072:Antibiotic Prophylaxis; D001733:Bites and Stings / Q000382:microbiology*; D025065:Borrelia burgdorferi / Q000302:isolation & purification*; D002648:Child; D018450:Disease Progression; D006801:Humans; D008193:Lyme Disease / Q000175:diagnosis / Q000188:drug therapy* / Q000382:microbiology / Q000517:prevention & control; D022123:Lyme Disease Vaccines / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use; D013987:Ticks
chemical_list: D000900:Anti-Bacterial Agents; D022123:Lyme Disease Vaccines